Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma

Current Oncology

B.J. Wood¹  C.W. Hong³  S.K. Libutti² 

[1] National Institutes of Health Clinical Center, National Institutes of Health;Albert Einstein College of Medicine, National Institutes of Health;National Institutes of Health Clinical Center, Cleveland Clinic

关键词: RFA;    ablation;    hepatocellular carcinoma;    doxorubicin;    liposomes;   

DOI  :  

学科分类：肿瘤学

来源: Multimed, Inc.

【 摘 要 】

Radiofrequency ablation (rfa) is a standard treatment for small, unresectable hepatocellular carcinomas (hccs). However, rfa for larger tumours is less successful, and intravenous lyso-thermosensitive liposomal doxorubicin during rfa is one technique postulated to potentially address that limitation. This drug-plus-device combination therapy was used to completely treat a hcc in a patient who underwent liver transplantation 79 days later.

【 授权许可】

Unknown